NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

美國視網膜圖譜(2021年):Med/Op Index(TM)目錄分析

2021 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index(TM) Analysis

出版商 Market Scope, LLC 商品編碼 1009630
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
美國視網膜圖譜(2021年):Med/Op Index(TM)目錄分析 2021 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index(TM) Analysis
出版日期: 2021年06月09日內容資訊: 英文
簡介

本報告以美國的視網膜疾病市場為焦點,依據Med/Op Index,提供美國85個城市的人口統計,視網膜治療的機會,各城市圈的視網膜手術數量及視網膜專門醫生數的估計,市場策略性洞察能力,玻璃體內(IVT)給藥及玻璃體手術的眼科診療所相關資訊等彙整資料。

玻璃體(IVT)注射及玻璃體手術的手術數量:各城市圈

目錄

The Retina Atlas offers strategic insights into the top potential markets in the US by providing demographic information of selected metropolitan populations; profiles of selected metropolitan areas and applicable retinal treatment opportunity; current estimates for retina surgery volume by metropolitan area; current estimates for retina surgeons by metropolitan area; and a comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies.

The allocation of the population with retinal disease is calculated by combining the prevalence rates by age group from Market Scope's comprehensive retinal disease model with the age distribution of each geography. We also consider the varying rates of adult diabetes throughout the US. The different procedure volumes and practice size are considered in the distribution of procedures. Retinal treatment opportunity is estimated with multi-factor criteria using Market Scope's MedOp Index™ Analysis. Factors in this analysis include the demographic makeup of a geography-including age distribution and health metrics-and the volume and concentration of retina surgeons.

The "2021 United States Retina Atlas"provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. The atlas identifies potential based on a variety of factors, which allows us to rank metros by opportunity and offers strategic insights into the top potential markets in the US.

Featured in the atlas is the Med/Op Index™ Analysis, a proprietary new index developed to estimate the market opportunity for each metropolitan area. This proprietary index identifies the potential based on patient demographics, procedure volumes, retina providers, and other factors.

The Retina Atlas can be used to evaluate market potential, identify growth opportunities, and allocate sales resources.